Phyu Thin Naing

Dr. Phyu Thin Naing


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Surgical Education
Verified
Journal Article
Closed access
ALAlbert Thein Lwin
Albert Thein Lwin
TLThein Lwin
Thein Lwin
PNPhyu Thin Naing
Phyu Thin Naing
YOYee Oo
Yee Oo
DKDavid Kidd
David Kidd
KSKent A. Stevens
Kent A. Stevens

8 June 2025 in Pathobiology
Verified
Journal Article
Open access
NSNeha Seth
Neha Seth
PNPhyu Thin Naing
Phyu Thin Naing
RSRam Singh
Ram Singh
SGSaroja Geetha
Saroja Geetha
KRKalpana Reddy
Kalpana Reddy
WTWayne Tam
Wayne Tam
Introduction Transdifferentiation of multiple myeloma (MM) into histiocytic sarcoma (HS) is exceptionally rare. We report a unique case, confirming this phenomenon through cytogenetics and molecular analyses. Case Presentation A 46-year-old woman with high-risk light chain MM developed extramedullary disease despite multiple lines of therapy. Biopsies revealed atypical histiocytic proliferation consistent with HS. Shared immunoglobulin gene rearrangements, cytogenetic alterations, and gene mutations, including a rare BRAF L485F, confirmed clonal relatedness between the two neoplasms. IGH::MAF translocation specific to MM and IGVH somatic hypermutation in HS suggests divergent evolution from a putative germinal center B-cell (GCB) precursor. Conclusions This case highlights lineage plasticity of MM to undergo HS transdifferentiation, potentially mediated through a mutated common GCB precursor antecedent to the plasma cell stage, and the subsequent development of HS and MM through acquisition of additional genetic events. Recognition of this exceptional phenomenon and understanding its underlying mechanism have implications for diagnosis, classification, and personalized treatment.

1 May 2020
Verified
Conference Paper
Open access
PNPhyu Thin Naing
Phyu Thin Naing
HEH. Elshakh
H. Elshakh
JRJ.A.C. Rhee
J.A.C. Rhee
CCC. Castaneda
C. Castaneda
YGY. Grewal
Y. Grewal
SAS. Aksenov
S. Aksenov

2 November 2023 in Blood
Verified
Journal Article
Open access
EZEdward Zhou
Edward Zhou
BBBoisclair Boisclair
Boisclair Boisclair
PNPhyu Thin Naing
Phyu Thin Naing
RTRicha Thakur
Richa Thakur
BGBradley Goldberg
Bradley Goldberg
JKJonathan E Kolitz
Jonathan E Kolitz
Disclosures. No relevant conflicts of interest to declare.Figure 1

2 November 2023 in Blood
Verified
Journal Article
Open access
RTRicha Thakur
Richa Thakur
BBBoisclair Boisclair
Boisclair Boisclair
PNPhyu Thin Naing
Phyu Thin Naing
EZEdward Zhou
Edward Zhou
BGBradley Goldberg
Bradley Goldberg
DCDavid W Chitty
David W Chitty
Disclosures. No relevant conflicts of interest to declare.Figure 1

2 November 2023 in Blood
Verified
Journal Article
Open access
PNPhyu Thin Naing
Phyu Thin Naing
BBBoisclair Boisclair
Boisclair Boisclair
EZEdward Zhou
Edward Zhou
RTRicha Thakur
Richa Thakur
EJErin Jou
Erin Jou
JKJonathan E Kolitz
Jonathan E Kolitz
Disclosures. No relevant conflicts of interest to declare.Figure 1